Saturday, April 26, 2025
Blogger Facebook Linkedin Pinterest Twitter Youtube

Tag: CuraTeQ Biologics

CuraTeQ

CuraTeQ Biologics’ successful phase 1 trial of BP11

HTP Desk - 0
CuraTeQ Biologics, a subsidiary of Aurobindo Pharma, announced that their Omalizumab biosimilar candidate BP11 has met the Phase 1 trial endpoints vis-à-vis the EU...
Healthtekpak delivers daily news, updates, analysis, case studies and industry scoops related to the health industry.
Contact us: editor@ippgroup.in
Blogger Facebook Linkedin Pinterest Twitter Youtube
© 2024 All content (text and/or media) is intellectual property of IPP Catalog Publications Pvt. Ltd.

This function has been disabled for HealthTekPak.

error: Content is protected !!